| Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological … C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ... Annals of the rheumatic diseases 73 (6), 990-999, 2014 | 742 | 2014 |
| Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice C Fülöp, S Szántó, D Mukhopadhyay, T Bárdos, RV Kamath, MS Rugg, ... Oxford University Press for The Company of Biologists Limited 130 (10), 2253 …, 2003 | 469 | 2003 |
| Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ... Arthritis & Rheumatology 71 (2), 258-270, 2019 | 318 | 2019 |
| Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis P Szodoray, Z Szabó, A Kapitány, Á Gyetvai, G Lakos, S Szántó, G Szücs, ... Autoimmunity reviews 9 (3), 140-143, 2010 | 268 | 2010 |
| Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr, AP Brézin, SP Chee, ... Ophthalmology 125 (5), 757-773, 2018 | 255 | 2018 |
| Accelerated atherosclerosis in rheumatoid arthritis Z Szekanecz, G Kerekes, H Der, Z Sandor, Z Szabo, A Vegvari, ... Annals of the New York Academy of Sciences 1108 (1), 349-358, 2007 | 202 | 2007 |
| Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment P Soltész, G Kerekes, H Dér, G Szücs, S Szántó, E Kiss, E Bodolay, ... Autoimmunity reviews 10 (7), 416-425, 2011 | 153 | 2011 |
| Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE) M Dougados, J Braun, S Szanto, B Combe, M Elbaz, P Geher, G Thabut, ... Annals of the rheumatic diseases 70 (5), 799-804, 2011 | 145 | 2011 |
| Assessment of subclinical vascular disease associated with ankylosing spondylitis N Bodnár, G Kerekes, I Seres, G Paragh, J Kappelmayer, ZG Némethné, ... The Journal of Rheumatology 38 (4), 723-729, 2011 | 145 | 2011 |
| Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice S Szántó, T Koreny, K Mikecz, TT Glant, Z Szekanecz, J Varga Arthritis research & therapy 9, 1-7, 2007 | 140 | 2007 |
| Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets? Z Szekanecz, L Soós, Z Szabó, A Fekete, A Kapitány, A Végvári, S Sipka, ... Clinical reviews in allergy & immunology 34, 26-31, 2008 | 136 | 2008 |
| A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes EJ Kucharz, V Kovalenko, S Szántó, O Bruyère, C Cooper, JY Reginster Current medical research and opinion 32 (6), 997-1004, 2016 | 116 | 2016 |
| Enhanced neutrophil extravasation and rapid progression of proteoglycan‐induced arthritis in TSG‐6–knockout mice S Szántó, T Bárdos, I Gál, TT Glant, K Mikecz Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 115 | 2004 |
| Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype A Hanyecz, SE Berlo, S Szántó, CPM Broeren, K Mikecz, TT Glant Arthritis & Rheumatism 50 (5), 1665-1676, 2004 | 106 | 2004 |
| Chemokines in rheumatic diseases Z Szekanecz, G Szucs, S Szántó, AE Koch Current drug targets 7 (1), 91-102, 2006 | 105 | 2006 |
| Cartilage‐specific constitutive expression of TSG‐6 protein (product of tumor necrosis factor α–stimulated gene 6) provides a chondroprotective, but not antiinflammatory … TT Glant, RV Kamath, T Bárdos, I Gál, S Szántó, YM Murad, JD Sandy, ... Arthritis & Rheumatism 46 (8), 2207-2218, 2002 | 100 | 2002 |
| Systemic sclerosis–rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity G Szücs, Z Szekanecz, E Zilahi, A Kapitány, S Baráth, S Szamosi, ... Oxford University Press 46 (6), 989-993, 2007 | 83 | 2007 |
| Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis O Timar, P Soltesz, S Szamosi, H Der, S Szanto, Z Szekanecz, G Szuecs The Journal of rheumatology 35 (7), 1329-1333, 2008 | 82 | 2008 |
| Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis K Gulyás, Á Horváth, E Végh, A Pusztai, Á Szentpétery, Z Pethö, A Váncsa, ... Clinical rheumatology 39, 167-175, 2020 | 77 | 2020 |
| Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B* 2705 subtype in Hungarian … B Pazár, E Safrany, P Gergely, S Szántó, Z Szekanecz, G Poór The Journal of rheumatology 37 (2), 379-384, 2010 | 74 | 2010 |
